[Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Volumn 30, Issue 2, 2009, Pages 179-183

  Kang, Wan li ^a   Xie, Yan guang ^b   Tan, Wei guo ^b   Chu, Nai hui ^b   Li, Liang ^b   You, Yong hong ^b   Yang, Ying zhou ^b   Wang, Xiao meng ^b   Yan, Xing lu ^b   Miao, Zi ping ^b   Duanmu, Hong jin ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLONE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; RIFAMPIN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 79958255855     PISSN: 02546450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)